-
NIH/3T3 Cells: Culture, QC, and Use
2026-09-10
NIH/3T3 Cells provide an adherent mouse fibroblast model for controlled cell expansion, cell transfection studies, viral proliferation research, and oncogene research. This guide translates the product dossier into a practical recovery, culture, assay-preparation, and QC workflow while clarifying that the product information does not establish quantitative assay performance, viral permissiveness, or clinical applicability.
-
Bifendate Inhibits Autophagy and Lipid Accumulation
2026-09-09
The reference study identifies Bifendate (DDB) as a multi-step autophagy inhibitor rather than merely a general hepatoprotective compound. Using cell-based lysosomal and lipid-accumulation models, the authors show that DDB disrupts autophagosome–lysosome fusion, lysosome acidification, and autophagic lysosome reformation while reducing oleic acid-induced lipid droplets.
-
Bifendate (DDB): Designing Better Liver Studies
2026-09-09
Bifendate (DDB) is a hepatoprotection agent with reported effects on lipid metabolism, autophagy, and drug transport. This evidence-driven guide shows how to distinguish compound-specific findings from transferable assay principles and design more interpretable liver research.
-
N1-Methylpseudo-UTP in Translational RNA Design
2026-09-08
N1-Methyl-Pseudouridine-5'-Triphosphate can convert RNA chemistry into a controllable experimental variable. This article connects in vitro transcription, RNA stability enhancement, and inhaled RNA immunotherapy while clarifying how to design assays that separate nucleotide effects from delivery biology.
-
gamma-Glu-Cys (γ-Glu-Cys) Workflow Guide
2026-09-08
gamma-Glu-Cys (γ-Glu-Cys) provides a defined intermediate for glutathione synthetase enzyme assays, glutathione metabolism research, and selected thiol-reactive peptide workflows. This guide covers preparation, storage, QC, and experimental boundaries; the material is for scientific research only and should not be used for diagnostic, therapeutic, or medical applications.
-
Radioiodinated Balsalazide for UC Imaging
2026-09-07
Sanad and colleagues developed and evaluated radioiodinated balsalazide as a colon-directed tracer for detecting ulcerative colitis in mice. The optimized labeling procedure, 24-hour stability assessment, and lesion-enriched biodistribution provide a practical preclinical framework while also showing why murine uptake data require careful validation before translation.
-
ATP as a Translational Readout in Glioblastoma
2026-09-05
Glioblastoma metabolism cannot be understood from glycolytic markers alone. This thought-leadership article connects PXDN–LDHA biology with practical ATP measurement, showing how a sensitive luminescent endpoint can strengthen mechanistic validation, tissue workflows, and translational decision-making.
-
MCL-1 Dependence in Breast Cancer: Apoptotic Function
2026-09-05
This 2021 Cell Death & Differentiation study shows that established breast tumors depend on MCL-1 primarily for its canonical anti-apoptotic activity, rather than for unrelated non-canonical functions. By combining acute genetic deletion, MCL-1-selective pharmacological inhibition, and BAX/BAK epistasis, the work provides a mechanistic framework for interpreting MCL-1-targeted therapy and stem-cell phenotypes.
-
Toremifene and the Calcium Metastasis Frontier
2026-09-04
Toremifene offers translational researchers a way to interrogate estrogen receptor biology alongside the TSPAN18–STIM1 calcium axis implicated in prostate cancer bone metastasis. This article turns that mechanistic intersection into a disciplined experimental and strategic research framework.
-
ARCA EGFP mRNA (5-moUTP) Workflow Guide
2026-09-04
Build a reproducible fluorescence-based transfection control around modified, polyadenylated mRNA rather than relying on endpoint microscopy alone. This guide connects ARCA capping, 5-moUTP modification, RNase-aware handling, and storage discipline to practical mRNA transfection in mammalian cells.
-
Protease Inhibitor Cocktail for OXPHOS Assays
2026-09-03
Protect intact mitochondrial, signaling, and interaction proteins during cancer-cell and tissue extraction with an EDTA-free, broad-spectrum formulation. This workflow connects protease control to the dual-genome OXPHOS mechanism reported for LRPPRC inhibition and dasatinib, with practical guidance for Western blotting, Co-IP, pull-down, and kinase assays.
-
Telmisartan: AT1R Logic in Cardiac Hypertrophy
2026-09-03
Telmisartan is more than an angiotensin II receptor antagonist: it can serve as an upstream mechanistic boundary condition in cardiac hypertrophy experiments. This article connects AT1R blockade with RIP3/CaMKII biology and provides an assay-planning framework for cardiovascular disease research.
-
Doxycycline hyclate for MMP and BBB research
2026-09-02
Doxycycline hyclate provides a practical way to interrogate MMP-2/MMP-9-driven barrier injury while connecting molecular, ultrastructural, and behavioral endpoints. This workflow translates a mouse neurotoxicology study into adaptable guidance for BBB, vascular, antiviral, and antimalarial research.
-
Pterostilbene Delays Dermal Fibroblast Senescence
2026-09-02
Zhou et al. show that pterostilbene reduces senescence phenotypes in human dermal fibroblasts by improving mitochondrial morphology, membrane potential, respiration, and mitophagy-associated quality control. Using UVB-induced stress, replicative senescence, and a mouse skin-damage model, the study connects mitochondrial maintenance with collagen preservation and provides a useful framework for evaluating dermal aging interventions.
-
α-Linolenic Acid C3934: Reliable Cell Assays
2026-09-01
Learn how α-Linolenic Acid (SKU C3934) can support more interpretable cell viability, proliferation, and cytotoxicity workflows through defined identity, practical solvent options, controlled dosing, and appropriate data interpretation. The article addresses common laboratory failure points while distinguishing product-supported facts from assay-specific recommendations.